Dialectic Therapeutics, Inc.

Amendment
CIK: 0001750926·Biotechnology·DELAWARE·Filed: Feb 11, 2021
Total Offering

$6,350,000

Amount Sold

$6,350,000

Investors

27

First Sale

Dec 15, 2020

Offering Details

Type
Debt, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2018
Non-Accredited Investors
No

Related Persons

NameRole
Robert Hromas
Related Person
Daohong Zhou
Related Person
David Genecov
Related Person
John D. Harkey
Related Person
Joshua Sills
Related Person

Company

Dialectic Therapeutics, Inc.

12200 N STEMMONS FREEWAY

DALLAS, TX, 75234

9728888179

SEC Filing

0001750926-21-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Dialectic Therapeutics, Inc. Form D Filing — $6,350,000 | FilingFlow